Chronic tryptophan deprivation attenuates gating deficits induced by 5-HT(1A), but not 5-HT₂ receptor activation

Eur Neuropsychopharmacol. 2013 Oct;23(10):1329-35. doi: 10.1016/j.euroneuro.2012.10.009. Epub 2012 Nov 6.

Abstract

The neurotransmitter serotonin (5-hydroxytryptamine; 5-HT) exerts a multifaceted function in the modulation of information processing, through the activation of multiple receptor families. In particular, stimulation of 5-HT(1A) and 5-HT(2A) receptors leads to sensorimotor gating impairments and perceptual perturbations. Previous evidence has shown that chronic deprivation of L-tryptophan (TRP), the precursor of 5-HT, results in marked reductions of 5-HT brain levels, as well as neuroplastic alterations in 5-HT(1A) and 5-HT(2A) expression and/or signaling. Building on these premises, in the present study we tested whether a prolonged TRP deprivation may differentially impact the roles of these receptors in the regulation of the prepulse inhibition (PPI) of the acoustic startle reflex, a dependable index of gating. Male Sprague-Dawley rats were fed for 14 days with either a regimen with negligible TRP content (TR-) or the same diet supplemented of TRP (TR+). At the end of this schedule, rats were treated with the prototypical 5-HT(1A) receptor agonist 8-OH-DPAT (62.5-250 μg/kg, subcutaneous, s.c.) or the 5-HT₂ receptor agonist DOI (0.25-1 mg/kg, s.c.). Notably, the PPI deficits induced by 8-OH-DPAT in TR- rats were significantly milder than those observed in their TR+ counterparts; these effects were fully prevented by the 5-HT(1A) antagonist WAY-100135 (10 mg/kg, intraperitoneal). Conversely, TRP deprivation did not affect the PPI-disrupting properties of DOI. These findings suggest that prolonged 5-HT depletion attenuates the influence of 5-HT(1A), but not 5-HT₂ receptors on sensorimotor gating, confirming the distinct mechanisms of these two targets in PPI regulation.

Keywords: 5-HT(1A); 5-HT(2); Prepulse inhibition; Serotonin; Startle; Tryptophan.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acoustic Stimulation
  • Animals
  • Behavior, Animal / drug effects
  • Brain / drug effects
  • Brain / metabolism
  • Dyskinesia, Drug-Induced / diet therapy*
  • Gait Disorders, Neurologic / chemically induced
  • Gait Disorders, Neurologic / diet therapy*
  • Male
  • Nerve Tissue Proteins / agonists
  • Nerve Tissue Proteins / antagonists & inhibitors
  • Nerve Tissue Proteins / metabolism
  • Neural Inhibition / drug effects
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Serotonin, 5-HT1A / chemistry
  • Receptor, Serotonin, 5-HT1A / metabolism*
  • Receptors, Serotonin, 5-HT2 / chemistry
  • Receptors, Serotonin, 5-HT2 / metabolism
  • Reflex, Startle / drug effects
  • Sensory Gating / drug effects*
  • Serotonergic Neurons / drug effects*
  • Serotonergic Neurons / metabolism
  • Serotonin 5-HT1 Receptor Agonists / toxicity*
  • Serotonin 5-HT1 Receptor Antagonists / pharmacology
  • Serotonin 5-HT2 Receptor Agonists / toxicity
  • Tryptophan / antagonists & inhibitors
  • Tryptophan / deficiency*

Substances

  • Nerve Tissue Proteins
  • Receptors, Serotonin, 5-HT2
  • Serotonin 5-HT1 Receptor Agonists
  • Serotonin 5-HT1 Receptor Antagonists
  • Serotonin 5-HT2 Receptor Agonists
  • Receptor, Serotonin, 5-HT1A
  • Tryptophan